Jpmorgan Chase & Co »

Oncolytics Biotech shares owned by Jpmorgan Chase & Co

Quarter-by-quarter ownership of Oncolytics Biotech (ONCY) shares owned by Jpmorgan Chase & Co from 13F filings

Historical chart of Jpmorgan Chase & Co investment in Oncolytics Biotech

Tip: Access up to 7 years of quarterly data

All positions including Oncolytics Biotech held by Jpmorgan Chase & Co consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Oncolytics Biotech by Jpmorgan Chase & Co

Quarter filed Position value Share count Share price at filing
2023-12-31 $16k 12k 1.35
2021-12-31 $50k 36k 1.38
2021-03-31 $214k 56k 3.80
2020-09-30 $101k 17k 6.13
2020-06-30 $10k 5.3k 1.89

More positions owned by Jpmorgan Chase & Co

Microsoft Corp Common (MSFT)
Apple Common (AAPL)
Amazon Common (AMZN)
Spdr S&p 500 Etf Trust Fund (SPY)
Nvidia Corporation Common (NVDA)
Meta Platforms Common (META)
Unitedhealth Group Common (UNH)
Vanguard Total Intl Bond Etf Fund (BNDX)
Alphabet Common (GOOG)
Eli Lilly & Co Common (LLY)
Mastercard Incorporated Common (MA)
Alphabet Common (GOOGL)
Abbvie Common (ABBV)
Vanguard Total Bond Market Fund (BND)
Tesla Common (TSLA)

View all positions for Jpmorgan Chase & Co

Top funds holding Oncolytics Biotech

International Assets Investment Management
Millennium Management
Citadel Advisors
Commonwealth Equity Services
Royal Bank of Canada
Long Focus Capital Management
Bank Of Montreal
Ausdal Financial Partners
Brave Asset Management
Two Sigma Securities
C2P Capital Advisory Group, LLC d.b.a. Prosperity Capital Advisors
Banque Cantonale Vaudoise
Headinvest
Jpmorgan Chase & Co
Kingsview Wealth Management

View all funds holding Oncolytics Biotech